SURF6 knockdown does not disturb morphology of HeLa cells. by Anastasiia Moraleva (16548419)

Subjects:

Benchmarking DFT Accuracy in Predicting O 1s Binding Energies on Metals by Elizabeth E. Happel (22391811)

Subjects:

Benchmarking DFT Accuracy in Predicting O 1s Binding Energies on Metals by Elizabeth E. Happel (22391811)

Subjects:

The computed weighted sum of type I (dark gray) and type II (light gray) errors ( by Farrokh Habibzadeh (12256529)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Neither PDK4 nor HMGCS2 overexpression increases β-oxidation related enzymes. by Shota Tanaka (339198)

Percentages of concentration changes in TNF-α, IL-6, and IFN-γ in co-culture of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

Subjects:

The number of expected vaccinations decreases with the expected vaccination time, whereas the peak of infections increases. by Simon K. Schnyder (16632244)

SURF6 overexpression does not disturb morphology of HeLa cells [31]. by Anastasiia Moraleva (16548419)

Subjects:

Costs and Benefits of Popular <i>P</i>‑Value Correction Methods in Three Models of Quantitative Omic Experiments by Steven R. Shuken (14500192)

“…We show how increasing sample size, decreasing variability, or increasing effect size can enable the detection of all true changes while still correcting <i>p</i>-values, and we present basic guidelines for omic experimental design. …”

Graph showing relationship between age and bone mass, adapted from [2] Fig 6.23. by Nourridine Siewe (5081834)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Species occurrence along the NO₃¯ gradient (sorted by decreasing 25th percentile values). by Willem Kaijser (12872371)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Relative expression levels in TNF-α, IL-6, and p53 in co-culture and CM treatment of hypoxic and normoxic PANC-1 cells with CD8+ T-cells. by Eiman Abdo (20642254)

Subjects:

SURF6 co-localizes with ITS2 part of pre-rRNA in the nucleoli of HeLa cells. by Anastasiia Moraleva (16548419)

Subjects:

Network of cells and proteins in bone remodeling with the disruptive effects of age-related exosomal miRNAs and IL-6. by Nourridine Siewe (5081834)

Subjects: